This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: An Update of Anthraquinone Derivatives Emodin, Diacerein, and Catenarin in Diabetes, Evidence-based Complementary and Alternative Medicine, September 2021, Hindawi Publishing Corporation,
DOI: 10.1155/2021/3313419.
You can read the full text:
The following have contributed to this page
